Niagen Bioscience, Inc.
NAGE· Nasdaq
NAGENiagen Bioscience, Inc.
Quarterly figures for Niagen Bioscience, Inc., with source filings when available.
65 quarters. Jul 3, 2010 to Jun 30, 2026. USD.
Niagen Bioscience, Inc. has filed its 10-Q within 31 to 38 days of period end across its last 8 quarters. The 10-K runs 63 to 73 days.
Niagen Bioscience, Inc. · CIK 1386570 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 4, 2026 · after-hours | Aug 4, 2026 | 35 d | 10-Q | $29.79M | −4.3% | $0.01 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 6, 2026 · after-hours |
| May 6, 2026 |
| 36 d |
| 10-Q |
| $31.47M |
| +3.3% |
| $0.07 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 4, 2026 · after-hours | Mar 4, 2026 | 63 d | 10-K | $33.84M | +16.2% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 4, 2025 · after-hours | Nov 4, 2025 | 35 d | 10-Q | $33.99M | +32.9% | $0.05 | |
| Q2 2025 | Jun 30, 2025 | Aug 6, 2025 · after-hours | Aug 6, 2025 | 37 d | 10-Q | $31.12M | +36.8% | $0.04 | |
| Q1 2025 | Mar 31, 2025 | May 7, 2025 · after-hours | May 7, 2025 | 37 d | 10-Q | $30.48M | +37.6% | $0.06 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 4, 2025 · after-hours | Mar 4, 2025 | 63 d | 10-K | $29.13M | +37.4% | — | |
| Q3 2024 | Sep 30, 2024 | Oct 31, 2024 · after-hours | Oct 31, 2024 | 31 d | 10-Q | $25.58M | +31.2% | $0.02 | |
| Q2 2024 | Jun 30, 2024 | Aug 7, 2024 · after-hours | Aug 7, 2024 | 38 d | 10-Q | $22.74M | +11.9% | $0.00 | |
| Q1 2024 | Mar 31, 2024 | May 8, 2024 · after-hours | May 8, 2024 | 38 d | 10-Q | $22.15M | −1.8% | -$0.01 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 6, 2024 · after-hours | Mar 6, 2024 | 66 d | 10-K | $21.20M | +1.0% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 8, 2023 · after-hours | Nov 8, 2023 | 39 d | 10-Q | $19.50M | +14.3% | -$0.01 | |
| Q2 2023 | Jun 30, 2023 | Aug 9, 2023 · after-hours | Aug 9, 2023 | 40 d | 10-Q | $20.32M | +21.5% | -$0.03 | |
| Q1 2023 | Mar 31, 2023 | May 10, 2023 · after-hours | May 10, 2023 | 40 d | 10-Q | $22.56M | +30.7% | -$0.03 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 8, 2023 · after-hours | Mar 8, 2023 | 67 d | 10-K | $21.00M | +18.2% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 2, 2022 · after-hours | Nov 2, 2022 | 33 d | 10-Q | $17.06M | −1.4% | -$0.01 | |
| Q2 2022 | Jun 30, 2022 | Aug 10, 2022 · after-hours | Aug 10, 2022 | 41 d | 10-Q | $16.73M | −5.5% | -$0.09 | |
| Q1 2022 | Mar 31, 2022 | May 12, 2022 · after-hours | May 12, 2022 | 42 d | 10-Q | $17.26M | +17.5% | -$0.11 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Mar 9, 2022 · after-hours | Mar 14, 2022 | 73 d | 10-K | $17.76M | +15.0% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 3, 2021 | 34 d | 10-Q | $17.31M | +22.1% | -$0.13 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 3, 2021 | 34 d | 10-Q | $17.70M | +15.8% | -$0.08 | |
| Q1 2021 | Mar 31, 2021 | — | May 6, 2021 | 36 d | 10-Q | $14.68M | +2.4% | -$0.12 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Mar 12, 2021 | 71 d | 10-K | $15.45M | +18.0% | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 4, 2020 | 35 d | 10-Q | $14.18M | +17.6% | -$0.07 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 6, 2020 | 37 d | 10-Q | $15.29M | +37.7% | -$0.06 | |
| Q1 2020 | Mar 31, 2020 | — | May 18, 2020 | 48 d | 10-Q | $14.35M | +42.8% | -$0.10 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | — | Mar 10, 2020 | 70 d | 10-K | $13.09M | +44.4% | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 12, 2019 | 43 d | 10-Q | $12.05M | +48.4% | -$0.12 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 7, 2019 | 38 d | 10-Q | $11.10M | +42.3% | -$0.14 | |
| Q1 2019 | Mar 31, 2019 | — | May 9, 2019 | 39 d | 10-Q | $10.05M | +53.0% | -$0.15 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | — | Mar 7, 2019 | 66 d | 10-K | $9.07M | +20.4% | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 7, 2018 | 38 d | 10-Q | $8.12M | +33.5% | -$0.16 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 9, 2018 | 40 d | 10-Q | $7.80M | +85.0% | -$0.15 | |
| Q1 2018 | Mar 31, 2018 | — | May 10, 2018 | 40 d | 10-Q | $6.57M | — | -$0.15 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 30, 2017 | — | Mar 15, 2018 | 75 d | 10-K | $7.53M | +69.1% | -$0.17 | |
| Q3 2017 | Sep 30, 2017 | — | Nov 9, 2017 | 40 d | 10-Q | $6.08M | +54.5% | $0.04 | |
| Q2 2017 | Jul 1, 2017 | — | Aug 10, 2017 | 40 d | 10-Q | $4.22M | −43.2% | -$0.07 | |
| Q1 2017 | Apr 1, 2017 | — | May 11, 2017 | 40 d | 10-Q | — | — | -$0.05 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | — | Mar 16, 2017 | 75 d | 10-K | $4.45M | +2.0% | -$0.06 | |
| Q3 2016 | Oct 1, 2016 | — | Nov 10, 2016 | 40 d | 10-Q | $3.94M | −37.4% | -$0.03 | |
| Q2 2016 | Jul 2, 2016 | — | Aug 11, 2016 | 40 d | 10-Q | $7.42M | +21.7% | $0.00 | |
| Q1 2016 | Apr 2, 2016 | — | May 12, 2016 | 40 d | 10-Q | $5.85M | +11.2% | $0.01 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Jan 2, 2016 | — | Mar 17, 2016 | 75 d | 10-K | $4.36M | +2.9% | -$0.04 | |
| Q3 2015 | Oct 3, 2015 | — | Nov 12, 2015 | 40 d | 10-Q | $6.29M | +51.9% | $0.00 | |
| Q2 2015 | Jul 4, 2015 | — | Aug 13, 2015 | 40 d | 10-Q | $6.10M | +58.2% | -$0.01 | |
| Q1 2015 | Apr 4, 2015 | — | May 14, 2015 | 40 d | 10-Q | $5.26M | +71.1% | -$0.03 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014 | Jan 3, 2015 | — | Mar 19, 2015 | 75 d | 10-K | $4.24M | +76.7% | -$0.03 | |
| Q3 2014 | Sep 27, 2014 | — | Nov 6, 2014 | 40 d | 10-Q | $4.14M | +52.3% | -$0.02 | |
| Q2 2014 | Jun 28, 2014 | — | Aug 12, 2014 | 45 d | 10-Q | $3.86M | +42.5% | -$0.05 | |
| Q1 2014 | Mar 29, 2014 | — | May 8, 2014 | 40 d | 10-Q | $3.07M | +31.7% | -$0.05 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013 | Dec 28, 2013 | — | Mar 27, 2014 | 89 d | 10-K | $2.40M | −31.8% | -$0.01 | |
| Q3 2013 | Sep 28, 2013 | — | Nov 21, 2013 | 54 d | 10-Q | $2.72M | −25.2% | -$0.01 | |
| Q2 2013 | Jun 29, 2013 | — | Aug 13, 2013 | 45 d | 10-Q | $2.71M | +1.4% | -$0.01 | |
| Q1 2013 | Mar 30, 2013 | — | May 10, 2013 | 41 d | 10-Q | $2.33M | +30.8% | $0.01 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012derived | Dec 29, 2012 | — | Mar 29, 2013 | 90 d | 10-K | $3.52M | — | — | |
| Q3 2012 | Sep 29, 2012 | — | Nov 8, 2012 | 40 d | 10-Q | $3.63M | +98.7% | -$0.02 | |
| Q2 2012 | Jun 30, 2012 | — | Aug 9, 2012 | 40 d | 10-Q | $2.67M | +37.8% | -$0.04 | |
| Q1 2012 | Mar 31, 2012 | — | May 10, 2012 | 40 d | 10-Q | $1.79M | −29.7% | -$0.05 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011derived | Dec 31, 2011 | — | Mar 15, 2012 | 75 d | 10-K | — | — | — | |
| Q3 2011 | Oct 1, 2011 | — | Nov 10, 2011 | 40 d | 10-Q | $1.83M | +17.0% | -$0.03 | |
| Q2 2011 | Jul 2, 2011 | — | Aug 11, 2011 | 40 d | 10-Q | $1.94M | −4.7% | -$0.03 | |
| Q1 2011 | Apr 2, 2011 | — | May 12, 2011 | 40 d | 10-Q | $2.54M | — | -$0.02 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010derived | Jan 1, 2011 | — | Mar 16, 2011 | 74 d | 10-K | — | — | — | |
| Q3 2010 | Oct 2, 2010 | — | Nov 16, 2010 | 45 d | 10-Q | $1.56M | — | -$0.01 | |
| Q2 2010 | Jul 3, 2010 | — | Aug 17, 2010 | 45 d | 10-Q | $2.03M | — | -$0.01 | |
